Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 96%
the feeling of a fight
78%
—
cervical leukoplakia —
40%
removal of the uterine body
88%
12%
scarring of the cervix —
28%
vaginal tears
66%
—
cervical resection —
27%
gases from the vagina
61%
—
endocervicitis —
27%
inflammation of postoperative scars
61%
—
human papillomavirus —
26%
impaired uterine function
77%
18%
cervical erosion —
25%
skin fibroma
55%
—
cervical diathermocoagulation —
25%
transverse position of the fetus
55%
—
cervix is deformed —
25%
generic tumor
54%
—
hyperkeratosis —
23%
white abundant
54%
—
warts —
23%
mom oncology
52%
—
cervical pregnancy —
23%
acute abdomen
51%
—
cervical cancer —
23%
postpartum bleeding
51%
—
uterine cancer —
22%
swelling of the upper part belly
50%
—
vaginal sarcoma —
22%
anatomically narrow pelvis
49%
—
postpartum cervical ulcer —
22%
nose palpation of the abdomen soreness in the epigastrium
48%
—
eroded uterine lining —
21%
female pelvic organs
68%
19%
mucous whites —
21%
damage to the uterus
46%
—
scar on the uterus —
20%
accumulation of gases in the stomach
46%
—
cervical hypertrophy —
19%
fighting
46%
—
cancer —
18%
intra-abdominal abscesses
45%
—
ureaplasmosis in women —
18%
skewed pelvis
45%
—
ureaplasmosis and mycoplasmosis —
17%
abdominal pain
45%
—
fine-grained —
17%
abdominal pain when pressing
44%
—
cervical dysplasia —
17%
gases in the stomach
44%
—
endocrine infertility —
17%
skin dystrophy
44%
—
lymphosarcoma —
17%
bleeding uterine
43%
—
menstruation irregular —
17%
natural childbirth
43%
—
STDs —
17%
scar inflammation
43%
—
clamidiosis in women —
16%
collapse
42%
—
hpv dna positive —
16%
external bleeding
42%
—
excess progesterone —
16%
bloating pain
41%
—
mycoplasmosis in women —
16%
consequences of surgery
41%
—
ureaplasmosis —
16%
purulent peritonitis
41%
—
anovulatory infertility —
15%
pain in the vagina
41%
—
white with an unpleasant odor —
15%
fibrosarcoma
40%
—
abortions —
15%
postoperative scars
40%
—
anovulation —
15%
pain due to flatulence
40%
—
short cervix —
15%
large fruit
40%
—
progesterone deficiency —
15%
operative delivery
40%
—
smell of blood is —
15%
tumour in the abdomen
39%
—
hypertrophy of the uterine body —
15%
complications of childbirth
39%
—
monthly short —
14%
vaginal discharge
57%
16%
hypertrophic scar —
14%
fibroma
39%
—
appendages of the uterus —
14%
peritonitis
38%
—
trauma —
14%
history of surgery
55%
15%
uterine infertility —
14%
pregnancy complications
37%
—
rashes symmetrical —
13%
shock states of various genesis
36%
—
adnexitis —
13%
ascites
36%
—
discharge with an unpleasant smell —
13%
suffocation
36%
—
from sex worse —
13%
large child
36%
—
vaginitis —
13%
bloating
36%
—
precancer —
13%
sensations in the hands
36%
—
mycoplasma —
13%
consequences of childbirth
47%
9%
clamidiosis —
13%
effects of shock
36%
—
inflammation of the ovaries —
13%
abscess
34%
—
salpingitis —
13%
pain when touched
34%
—
ovarian dysfunction —
12%
bone deformation
34%
—
lack of menstruation —
12%
pain in the intestines
34%
—
hormonal disorders —
12%
bacteremia
33%
—
birth trauma —
12%
sepsis
33%
—
angioplasty —
11%
digestive disorders
33%
—
omission of internal organs —
11%
dystrophy
32%
—
no discharge —
11%
acute condition
31%
—
skin compaction —
11%
presses
31%
—
infertility female —
11%
impaired gastric function
31%
—
cytomegalovirus —
11%
bloody discharge from the vagina
46%
13%
skin cancer —
11%
bleeding
30%
—
herpes —
10%
scarring
45%
13%
early development —
10%
diseases of the gastrointestinal tract
29%
—
vaccination —
10%
blood diseases
28%
—
shortened cycle —
10%
consequences of taking medications
38%
8%
pituitary gland diseases —
10%
endometritis
42%
12%
aggressive —
9%
inflammation
46%
16%
consequences of injuries —
9%
surgical infections
31%
9%
peptic ulcer —
9%
skin problems
28%
8%
patient's condition —
8%
consequences of infection
29%
12%
there are no complaints —
8%
uterine tumor
39%
22%
lowered —
7%
vulvovaginitis
38%
23%
increased —
7%
pregnancy
30%
15%
vulva infections
38%
23%
intra-phase infections
37%
23%
oncology
27%
17%